News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Artisan Pharma, Inc. And A-Bio Pharma Pte Ltd Announce Strategic Manufacturing Alliance on ART-123


9/18/2007 11:33:54 AM

WALTHAM, Mass. & SINGAPORE--(BUSINESS WIRE)--Artisan Pharma, Inc. and A-Bio Pharma Pte Ltd. today jointly announced that they have finalized a strategic and mutually exclusive manufacturing relationship on the process development, scale-up and manufacture of ART-123, a recombinant protein for the treatment of DIC (disseminated intravascular coagulation) in sepsis. A-Bio will undertake the various development and validation activities necessary to ensure further clinical development and commercial supply of ART-123 for Artisan, and, in return, Artisan will enter into a preferential and long term supply agreement with A-Bio. Specific terms of the relationship were not disclosed.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES